Novo Nordisk A/S : Novo Nordisk A/S: Novo Nordisk receives Complete Response Letter in the US for Tresiba® and Ryzodeg®

 Novo Nordisk A/S : Novo Nordisk A/S: Novo Nordisk receives Complete Response
                  Letter in the US for Tresiba® and Ryzodeg®

Company announcement No 11 / 2013

------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
the
information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE
HUG#1676898
 
Press spacebar to pause and continue. Press esc to stop.